KMT2A and renal fibrosis: MM-102 and OICR-9429 inhibited MLL1/WDR5 binding and suppressed p16INK4a expression by downregulating H3K4me3, attenuating renal fibrosis and senescence after renal ischemia-reperfusion injury (IRI) [36].